Cornelia Landersdorfer
Cornelia Landersdorfer
Verified email at
Cited by
Cited by
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens
AM Sandri, CB Landersdorfer, J Jacob, MM Boniatti, MG Dalarosa, ...
Clinical infectious diseases 57 (4), 524-531, 2013
Penetration of antibacterials into bone
CB Landersdorfer, JB Bulitta, M Kinzig, U Holzgrabe, F Sörgel
Clinical pharmacokinetics 48 (2), 89-124, 2009
Acrylamide: increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans
F Sörgel, R Weissenbacher, M Kinzig-Schippers, A Hofmann, M Illauer, ...
Chemotherapy 48 (6), 267-274, 2002
Pharmacokinetics and pharmacodynamics of ‘old’polymyxins: what is new?
PJ Bergen, CB Landersdorfer, J Zhang, M Zhao, HJ Lee, RL Nation, J Li
Diagnostic microbiology and infectious disease 74 (3), 213-223, 2012
Combination therapy for carbapenem-resistant Gram-negative bacteria
AP Zavascki, JB Bulitta, CB Landersdorfer
Expert review of anti-infective therapy 11 (12), 1333-1353, 2013
Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis
AA Agyeman, KL Chin, CB Landersdorfer, D Liew, R Ofori-Asenso
Mayo Clinic Proceedings 95 (8), 1621-1631, 2020
‘Old’antibiotics for emerging multidrug-resistant bacteria
PJ Bergen, CB Landersdorfer, HJ Lee, J Li, RL Nation
Current opinion in infectious diseases 25 (6), 626, 2012
Development of a new pre-and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT
JB Bulitta, A Bingölbali, BS Shin, CB Landersdorfer
The AAPS journal 13 (2), 201-211, 2011
Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers
WA Krueger, J Bulitta, M Kinzig-Schippers, C Landersdorfer, U Holzgrabe, ...
Antimicrobial agents and chemotherapy 49 (5), 1881-1889, 2005
Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus
CB Landersdorfer, WJ Jusko
Clinical pharmacokinetics 47 (7), 417-448, 2008
Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models
JB Bulitta, CB Landersdorfer
The AAPS journal 13 (2), 212-226, 2011
Colistin: how should it be dosed for the critically ill?
CB Landersdorfer, RL Nation
Seminars in respiratory and critical care medicine 36 (01), 126-135, 2015
Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design
CB Landersdorfer, NS Ly, H Xu, BT Tsuji, JB Bulitta
Antimicrobial agents and chemotherapy 57 (5), 2343-2351, 2013
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
NS Ly, JB Bulitta, GG Rao, CB Landersdorfer, PN Holden, A Forrest, ...
Journal of antimicrobial chemotherapy 70 (5), 1434-1442, 2015
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system
HY Lin, CB Landersdorfer, D London, R Meng, CU Lim, C Lin, S Lin, ...
PLoS computational biology 7 (2), e1001073, 2011
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling
JB Bulitta, NS Ly, CB Landersdorfer, NA Wanigaratne, T Velkov, R Yadav, ...
Antimicrobial agents and chemotherapy 59 (4), 2315-2327, 2015
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis
AM Sandri, CB Landersdorfer, J Jacob, MM Boniatti, MG Dalarosa, ...
Journal of Antimicrobial Chemotherapy 68 (3), 674-677, 2013
Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin
CB Landersdorfer, CMJ Kirkpatrick, M Kinzig-Schippers, JB Bulitta, ...
Antimicrobial agents and chemotherapy 51 (9), 3290-3297, 2007
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use
PJ Bergen, ZP Bulman, S Saju, JB Bulitta, C Landersdorfer, A Forrest, J Li, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (1 …, 2015
Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii
R Yadav, CB Landersdorfer, RL Nation, JD Boyce, JB Bulitta
Antimicrobial agents and chemotherapy 59 (4), 2286-2298, 2015
The system can't perform the operation now. Try again later.
Articles 1–20